Follow this preprint
Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
View ORCID ProfileNkgomeleng Lekodeba, View ORCID ProfileKatherine Snyman, View ORCID ProfileBrooke E Nichols, View ORCID ProfileLise Jamieson
doi: https://doi.org/10.1101/2024.12.13.24319006
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Nkgomeleng Lekodeba
1Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Katherine Snyman
1Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
Brooke E Nichols
1Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
3Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA
4Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Lise Jamieson
1Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
5South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

Posted March 19, 2025.
Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Nkgomeleng Lekodeba, Katherine Snyman, Brooke E Nichols, Lise Jamieson
medRxiv 2024.12.13.24319006; doi: https://doi.org/10.1101/2024.12.13.24319006
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3189)
- Dermatology (269)
- Emergency Medicine (472)
- Epidemiology (13171)
- Forensic Medicine (18)
- Gastroenterology (882)
- Genetic and Genomic Medicine (5004)
- Geriatric Medicine (464)
- Health Economics (767)
- Health Informatics (3151)
- Health Policy (1118)
- Hematology (418)
- HIV/AIDS (990)
- Medical Education (466)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4754)
- Nursing (253)
- Nutrition (705)
- Oncology (2446)
- Ophthalmology (695)
- Orthopedics (273)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1270)
- Primary Care Research (541)
- Public and Global Health (7318)
- Radiology and Imaging (1643)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (412)
- Surgery (528)
- Toxicology (68)
- Transplantation (227)
- Urology (196)